Mural Oncology (NASDAQ:MURA – Get Free Report) was downgraded by stock analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a report released on Tuesday, ...

Mural Oncology (NASDAQ:MURA – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Jones Trading in a note issued to investors on Tuesday,Benzinga reports. Separately, HC ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A new 1,100-foot-long mural has been added to Jacksonville's Emerald Trail, celebrating the history of the LaVilla and Brooklyn neighborhoods. The mural, led by artist Overstreet Ducasse ...

In the meantime, we encourage you to watch our livestream. ALBANY, Ga. (WALB) - A new mural in the Hartsfield-Jackson International Airport was finished recently. It honors President Jimmy Carter ...

An abundance of motivated young professionals is luring American businesses to base their global operations in Indian cities.

On Tuesday, Morgan Stanley (NYSE:MS) revised its rating for Mural Oncology (NASDAQ:MURA), shifting from "Overweight" to "Equal-weight." The change comes as Morgan Stanley analysts recalibrated their ...

WALTHAM, Mass - Mural Oncology plc (NASDAQ:MURA), a clinical-stage biopharmaceutical company valued at approximately $66 million, has announced the discontinuation of its phase 3 ARTISTRY-7 trial for ...

The biggest stories of the day delivered to your inbox.